XML 39 R26.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-Based Compensation Expenses

The Company recorded stock-based compensation expense within its consolidated statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

 

2023

 

Research and development expenses

 

$

48,097

 

 

$

31,369

 

 

$

11,600

 

General and administrative expenses

 

 

38,405

 

 

 

29,210

 

 

 

13,963

 

 

$

86,502

 

 

$

60,579

 

 

$

25,563

 

Summary of Share Based Payment Award Stock Options Range of Assumptions

The following table presents the range of assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted:

 

 

Year Ended December 31,

 

 

2025

 

2024

 

2023

Weighted average expected option term (years)

 

6.0

 

6.0

 

6.0

Range of expected stock price volatility

 

70% — 71%

 

72% — 76%

 

76% — 82%

Weighted average expected stock price volatility

 

71%

 

75%

 

80%

Range of risk-free interest rate

 

3.7% — 4.4%

 

3.5% — 4.6%

 

3.4% — 4.7%

Expected dividend rate

 

0%

 

0%

 

0%

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity since December 31, 2024:

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

Weighted

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

 

Average

 

 

Contractual

 

 

Intrinsic

 

 

 

Number

 

 

Exercise

 

 

Term

 

 

Value

 

 

 

of Shares

 

 

Price

 

 

(in years)

 

 

(in thousands)

 

Outstanding as of December 31, 2024

 

 

7,980,047

 

 

$

28.93

 

 

 

7.45

 

 

$

398,407

 

Granted

 

 

1,544,070

 

 

$

78.51

 

 

 

 

 

 

 

Exercised

 

 

(1,672,786

)

 

$

25.13

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(133,690

)

 

$

73.63

 

 

 

 

 

 

 

Outstanding as of December 31, 2025

 

 

7,717,641

 

 

$

38.90

 

 

 

6.90

 

 

$

476,355

 

Exercisable as of December 31, 2025

 

 

4,701,612

 

 

$

22.06

 

 

 

5.95

 

 

$

369,254

 

Summary of Restricted Stock Unit Activity

The following table summarizes the Company’s RSU activity since December 31, 2024:

 

Number of Shares

 

 

Weighted Average Grant-Date Fair Value

 

Outstanding as of December 31, 2024

 

 

716,921

 

 

$

75.13

 

Granted

 

 

657,148

 

 

$

78.05

 

Vested

 

 

(252,814

)

 

$

75.29

 

Forfeited

 

 

(30,139

)

 

$

77.97

 

Outstanding as of December 31, 2025

 

 

1,091,116

 

 

$

76.77